Status:
RECRUITING
Screening Strategy for Gastric Cancer Prevention
Lead Sponsor:
National Taiwan University Hospital
Conditions:
H. Pylori Infection
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
There are still some unsolved questions regarding population-based screening program for H. pylori infection to prevent gastric cancer, such as how to perform the optimal screening strategies. A prosp...
Detailed Description
Background: There are still some unsolved questions regarding population-based screening program for H. pylori infection to prevent gastric cancer, such as how to perform the optimal screening strateg...
Eligibility Criteria
Inclusion
- Adults aged 20 years or older
- Never screened and treated for H. pylori infection
Exclusion
- Ever undergone gastrectomy
- Patients with gastric cancer
- Have been screened or tested for H. pylori infection
- Ever received H. pylori eradication therapy
- Have taken proton pump inhibitor within two weeks
- Have taken antibiotics within two weeks
Key Trial Info
Start Date :
July 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2029
Estimated Enrollment :
4403 Patients enrolled
Trial Details
Trial ID
NCT05387005
Start Date
July 19 2022
End Date
April 30 2029
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan